NR AAZT

AU Baron,G.S.; Wehrly,K.; Dorward,D.W.; Chesebro,B.; Caughey,B.W.

TI Conversion of raft associated prion protein to the protease-resistant state requires insertion of PrPres (PrPsc) into contiguous membranes

QU EMBO Journal 2002 Mar 1; 21(5): 1031-40

IA http://www.pubmedcentral.gov/articlerender.fcgi?tool=pubmed&pubmedid=11867531

PT journal article

AB Prion protein (PrP) is usually attached to membranes by a glycosylphosphatidylinositol-anchor that associates with detergent-resistant membranes (DRMs), or rafts. To model the molecular processes that might occur during the initial infection of cells with exogenous transmissible spongiform encephalopathy (TSE) agents, we examined the effect of membrane association on the conversion of the normal protease-sensitive PrP isoform (PrP-sen) to the protease-resistant isoform (PrPres). A cell-free conversion reaction approximating physiological conditions was used, which contained purified DRMs as a source of PrP-sen and brain microsomes from scrapie-infected mice as a source of PrPres. Interestingly, DRM-associated PrP-sen was not converted to PrPres until the PrP-sen was either released from DRMs by treatment with phosphatidylinositol-specific phospholipase C (PI-PLC), or the combined membrane fractions were treated with the membrane-fusing agent polyethylene glycol (PEG). PEG-assisted conversion was optimal at pH 6-7, and acid pre-treating the DRMs was not sufficient to permit conversion without PI-PLC or PEG, arguing against late endosomes/lysosomes as primary compartments for PrP conversion. These observations raise the possibility that generation of new PrPres during TSE infection requires (i) removal of PrP-sen from target cells; (ii) an exchange of membranes between cells; or (iii) insertion of incoming PrPres into the raft domains of recipient cells.

MH Animals; Cell Membrane/*metabolism; Cell-Free System; Drug Resistance; Endopeptidases/*pharmacology; Glycosylphosphatidylinositols/*metabolism; Hydrogen-Ion Concentration; Membrane Fusion/drug effects; Membrane Microdomains/*metabolism; Mice; Microsomes/metabolism; Neuroblastoma/pathology; Phosphatidylinositol Diacylglycerol-Lyase; Phospholipase C/pharmacology; Polyethylene Glycols/pharmacology; PrPsc Proteins/drug effects/*metabolism; Protein Isoforms/*metabolism; Recombinant Fusion Proteins/metabolism; Research Support, Non-U.S. Gov't; Scrapie/metabolism; Tumor Cells, Cultured

AD Laboratory of Persistent Viral Diseases, NIAID, NIH, Rocky Mountain Laboratories, 903 South 4th Street, Hamilton, MT 59840, USA

SP englisch

PO England

EA pdf-Datei

Autorenindex - authors index
Startseite - home page